NTC 200Alternative Names: NTC-200
Latest Information Update: 10 Sep 2003
At a glance
- Originator Neurotech SA
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Age-related macular degeneration
Most Recent Events
- 08 Oct 2001 New profile
- 08 Oct 2001 Preclinical development for Age-related macular degeneration in USA (Intraocular)